These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 28838644

  • 21. Single port laparoscopic ileocaecal resection for Crohn's disease: a multicentre comparison with multi-port laparoscopy.
    Carvello M, de Groof EJ, de Buck van Overstraeten A, Sacchi M, Wolthuis AM, Buskens CJ, D'Hoore A, Bemelman WA, Spinelli A.
    Colorectal Dis; 2018 Jan; 20(1):53-58. PubMed ID: 28622435
    [Abstract] [Full Text] [Related]

  • 22. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease.
    Milsom JW, Hammerhofer KA, Böhm B, Marcello P, Elson P, Fazio VW.
    Dis Colon Rectum; 2001 Jan; 44(1):1-8; discussion 8-9. PubMed ID: 11805557
    [Abstract] [Full Text] [Related]

  • 23. Short-term outcomes of surgical treatment for primary ileocaecal Crohn's disease: Results of the Crohn's(urg) study, a multicentre, retrospective, comparative analysis between inflammatory and complicated phenotypes.
    Avellaneda N, Pellino G, Maroli A, Tottrup A, Bislenghi G, Colpaert J, D'Hoore A, Carvello M, Giorgi L, Juachon P, Harsløf S, de Buck Van Overstraeten A, Olivera PA, Gomez J, Holubar SD, Naranjo EL, Steele SR, Merchea A, Shaker A, Gallostra MM, Kraft M, Kotze PG, Maruyama BY, Wexner SD, Garoufalia Z, Chen Z, Hahnloser D, Rrupa D, Buskens C, Haanappel A, Warusavitarne J, Williams KJ, Christensen P, Wolthuis A, Potolicchio A, Spinelli A.
    Colorectal Dis; 2024 Jul; 26(7):1415-1427. PubMed ID: 38858815
    [Abstract] [Full Text] [Related]

  • 24. Assessment of long-term quality of life after laparoscopic and open surgery for Crohn's disease.
    Thaler K, Dinnewitzer A, Oberwalder M, Weiss EG, Nogueras JJ, Wexner SD.
    Colorectal Dis; 2005 Jul; 7(4):375-81. PubMed ID: 15932562
    [Abstract] [Full Text] [Related]

  • 25. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
    Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E, GETAID and the SPARE-Biocycle research group.
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):215-227. PubMed ID: 36640794
    [Abstract] [Full Text] [Related]

  • 26. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
    Feagan BG, Sandborn WJ, D'Haens G, Panés J, Kaser A, Ferrante M, Louis E, Franchimont D, Dewit O, Seidler U, Kim KJ, Neurath MF, Schreiber S, Scholl P, Pamulapati C, Lalovic B, Visvanathan S, Padula SJ, Herichova I, Soaita A, Hall DB, Böcher WO.
    Lancet; 2017 Apr 29; 389(10080):1699-1709. PubMed ID: 28411872
    [Abstract] [Full Text] [Related]

  • 27. Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients.
    Dajti G, Cardelli S, Calini G, Rizzello F, Gionchetti P, Flacco ME, Poggioli G, Rottoli M.
    Dig Liver Dis; 2024 Sep 29; 56(9):1497-1502. PubMed ID: 38616140
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease.
    Aaltonen G, Keränen I, Carpelan-Holmström M, Lepistö A.
    Eur J Gastroenterol Hepatol; 2018 Oct 29; 30(10):1143-1147. PubMed ID: 30024490
    [Abstract] [Full Text] [Related]

  • 29. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
    Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG, REACT Study Investigators.
    Lancet; 2015 Nov 07; 386(10006):1825-34. PubMed ID: 26342731
    [Abstract] [Full Text] [Related]

  • 30. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial.
    Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ, Hommes DW, Sprangers MA, Bemelman WA.
    Ann Surg; 2006 Feb 07; 243(2):143-9; discussion 150-3. PubMed ID: 16432345
    [Abstract] [Full Text] [Related]

  • 31. Laparoscopic-assisted versus conventional ileocolectomy for primary Crohn's disease: results of a comparative study.
    Makni A, Chebbi F, Ksantini R, Fétirich F, Bedioui H, Jouini M, Kacem M, Ben Mami N, Filali A, Ben Safta Z.
    J Visc Surg; 2013 Apr 07; 150(2):137-43. PubMed ID: 23092647
    [Abstract] [Full Text] [Related]

  • 32. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
    Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M, PROFILE Study Group.
    Lancet Gastroenterol Hepatol; 2024 May 07; 9(5):415-427. PubMed ID: 38402895
    [Abstract] [Full Text] [Related]

  • 33. Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients.
    Goyer P, Alves A, Bretagnol F, Bouhnik Y, Valleur P, Panis Y.
    Dis Colon Rectum; 2009 Feb 07; 52(2):205-10. PubMed ID: 19279413
    [Abstract] [Full Text] [Related]

  • 34. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W.
    Clin Gastroenterol Hepatol; 2014 Sep 07; 12(9):1494-502.e1. PubMed ID: 24440221
    [Abstract] [Full Text] [Related]

  • 35. Laparoscopic surgery in Crohn's disease.
    Bemelman WA, van der Made WJ, Mulder EJ, Ringers J, van Hogezand RA.
    Neth J Med; 1997 Feb 07; 50(2):S19-22. PubMed ID: 9050329
    [Abstract] [Full Text] [Related]

  • 36. Impact of Kono-S anastomosis on quality of life after ileocolic resection in Crohn's disease: an analysis from the SuPREMe-CD trial.
    Cricrì M, Tropeano FP, Rispo A, Miele A, Giglio MC, Castiglione F, De Palma GD, Luglio G.
    Colorectal Dis; 2024 Jul 07; 26(7):1428-1436. PubMed ID: 38881241
    [Abstract] [Full Text] [Related]

  • 37. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.
    Choy MC, Li Wai Suen CFD, Con D, Boyd K, Pena R, Burrell K, Rosella O, Proud D, Brouwer R, Gorelik A, Liew D, Connell WR, Wright EK, Taylor KM, Pudipeddi A, Sawers M, Christensen B, Ng W, Begun J, Radford-Smith G, Garg M, Martin N, van Langenberg DR, Ding NS, Beswick L, Leong RW, Sparrow MP, De Cruz P.
    Lancet Gastroenterol Hepatol; 2024 Nov 07; 9(11):981-996. PubMed ID: 39236736
    [Abstract] [Full Text] [Related]

  • 38. Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial.
    van de Wall BJM, Stam MAW, Draaisma WA, Stellato R, Bemelman WA, Boermeester MA, Broeders IAMJ, Belgers EJ, Toorenvliet BR, Prins HA, Consten ECJ, DIRECT trial collaborators.
    Lancet Gastroenterol Hepatol; 2017 Jan 07; 2(1):13-22. PubMed ID: 28404008
    [Abstract] [Full Text] [Related]

  • 39. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T, Danalioglu A, Novacek G, Armuzzi A, Hébuterne X, Travis S, Danese S, Reinisch W, Sandborn WJ, Rutgeerts P, Hommes D, Schreiber S, Neimark E, Huang B, Zhou Q, Mendez P, Petersson J, Wallace K, Robinson AM, Thakkar RB, D'Haens G.
    Lancet; 2017 Dec 23; 390(10114):2779-2789. PubMed ID: 29096949
    [Abstract] [Full Text] [Related]

  • 40. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
    D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van De Mierop FJ, Coche JR, van der Woude J, Ochsenkühn T, van Bodegraven AA, Van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D, Belgian Inflammatory Bowel Disease Research Group, North-Holland Gut Club.
    Lancet; 2008 Feb 23; 371(9613):660-667. PubMed ID: 18295023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.